These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29453383)

  • 1. Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.
    Dulai PS; Buckey JC; Raffals LE; Swoger JM; Claus PL; OʼToole K; Ptak JA; Gleeson MW; Widjaja CE; Chang JT; Adler JM; Patel N; Skinner LA; Haren SP; Goldby-Reffner K; Thompson KD; Siegel CA
    Am J Gastroenterol; 2018 Oct; 113(10):1516-1523. PubMed ID: 29453383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares.
    Dulai PS; Raffals LE; Hudesman D; Chiorean M; Cross R; Ahmed T; Winter M; Chang S; Fudman D; Sadler C; Chiu EL; Ross FL; Toups G; Murad MH; Sethuraman K; Holm JR; Guilliod R; Levine B; Buckey JC; Siegel CA
    Aliment Pharmacol Ther; 2020 Sep; 52(6):955-963. PubMed ID: 32745306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.
    Dulai PS; Jairath V
    Dig Dis Sci; 2021 Nov; 66(11):3740-3752. PubMed ID: 33185788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Narula N; Peerani F; Meserve J; Kochhar G; Chaudrey K; Hartke J; Chilukuri P; Koliani-Pace J; Winters A; Katta L; Shmidt E; Hirten R; Faleck D; Parikh MP; Whitehead D; Boland BS; Singh S; Sagi SV; Fischer M; Chang S; Barocas M; Luo M; Lasch K; Bohm M; Lukin D; Sultan K; Swaminath A; Hudesman D; Gupta N; Shen B; Kane S; Loftus EV; Siegel CA; Sands BE; Colombel JF; Sandborn WJ; Dulai PS
    Am J Gastroenterol; 2018 Sep; 113(9):1345. PubMed ID: 29946178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.
    Jairath V
    Am J Gastroenterol; 2018 Oct; 113(10):1432-1434. PubMed ID: 30158711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: The safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease.
    Dulai PS; Gleeson MW; Taylor D; Holubar SD; Buckey JC; Siegel CA
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1266-75. PubMed ID: 24738651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study.
    Pagoldh M; Hultgren E; Arnell P; Eriksson A
    Scand J Gastroenterol; 2013 Sep; 48(9):1033-40. PubMed ID: 23879825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial.
    Atreya R; Peyrin-Biroulet L; Klymenko A; Augustyn M; Bakulin I; Slankamenac D; Miheller P; Gasbarrini A; Hébuterne X; Arnesson K; Knittel T; Kowalski J; Neurath MF; Sandborn WJ; Reinisch W;
    Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1063-1075. PubMed ID: 33031757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis.
    Singh AK; Jha DK; Jena A; Kumar-M P; Sebastian S; Sharma V
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e564-e573. PubMed ID: 33905214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.
    Nishio M; Ishii Y; Hashimoto Y; Otake H; Ogashiwa T; Tsuda S; Yasuhara H; Saigusa Y; Kimura H; Maeda S; Kunisaki R
    Scand J Gastroenterol; 2018; 53(10-11):1236-1244. PubMed ID: 30353757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis.
    Vedamurthy A; Xu L; Luther J; Colizzo F; Garber JJ; Khalili H; Ananthakrishnan AN
    Dig Dis Sci; 2018 Oct; 63(10):2740-2746. PubMed ID: 29951797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Singh S; Allegretti JR; Siddique SM; Terdiman JP
    Gastroenterology; 2020 Apr; 158(5):1465-1496.e17. PubMed ID: 31945351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis.
    Church PC; Ho S; Sharma A; Tomalty D; Frost K; Muise A; Walters TD; Griffiths AM
    J Crohns Colitis; 2019 Aug; 13(8):982-989. PubMed ID: 30715240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease.
    Kaur H; Kochhar GS; Dulai PS
    Curr Opin Gastroenterol; 2023 Jul; 39(4):263-267. PubMed ID: 37265170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
    Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
    World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis.
    Sandborn WJ; Peyrin-Biroulet L; Zhang J; Chiorean M; Vermeire S; Lee SD; Kühbacher T; Yacyshyn B; Cabell CH; Naik SU; Klassen P; Panés J
    Gastroenterology; 2020 Feb; 158(3):550-561. PubMed ID: 31711921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study.
    Ma C; Beilman CL; Huang VW; Fedorak DK; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
    Can J Gastroenterol Hepatol; 2016; 2016():2079582. PubMed ID: 27478817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.